CN103463402B - Traditional Chinese medicine composition for infantile asthma and preparation method thereof - Google Patents

Traditional Chinese medicine composition for infantile asthma and preparation method thereof Download PDF

Info

Publication number
CN103463402B
CN103463402B CN201310440763.3A CN201310440763A CN103463402B CN 103463402 B CN103463402 B CN 103463402B CN 201310440763 A CN201310440763 A CN 201310440763A CN 103463402 B CN103463402 B CN 103463402B
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310440763.3A
Other languages
Chinese (zh)
Other versions
CN103463402A (en
Inventor
张桂菊
薛虹
陈鲁
王晓
周朋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University of Traditional Chinese Medicine
Original Assignee
李燕宁
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 李燕宁 filed Critical 李燕宁
Priority to CN201310440763.3A priority Critical patent/CN103463402B/en
Publication of CN103463402A publication Critical patent/CN103463402A/en
Application granted granted Critical
Publication of CN103463402B publication Critical patent/CN103463402B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a traditional Chinese medicine composition for infantile asthma, which is characterized by being prepared from the following raw medicines in parts by weight: 6-15 parts of herba artemisiae scopariae, 4-10 parts of fructus gardeniae, 4-10 parts of radix sophorae flavescentis, 4-10 parts of bulbus fritillariae thunbergii, 4-10 parts of radix glycyrrhizae, 1-5 parts of rhubarb, 1-5 parts of chamomile, 2-10 parts of folium eriobotryae, 2-8 parts of folium pyrrosiae and 1-5 parts of poria. According to the traditional Chinese medicine composition disclosed by the invention, the herba artemisiae scopariae, fructus gardeniae, rhubarb, radix sophorae flavescentis, bulbus fritillariae thunbergii, radix glycyrrhizae, chamomile, folium eriobotryae, folium pyrrosiae and poria are used as main medicine components; with the synergistic effect of the main medicine components, the functions of clearing heat and promoting diuresis, clearing lung heat and resolving phlegm and relieving cough are realized, the cause of asthma can be fundamentally solved, and an excellent treatment effect on infantile asthma is realized. Moreover, the invention also discloses a preparation method of the traditional Chinese medicine composition. The preparation process of the medicine is simple and easy to implement; without toxic or side effect, the traditional Chinese medicine composition is convenient to popularize and suitable for infants.

Description

Traditional Chinese medicine composition for infantile asthma and preparation method thereof
Technical field
The present invention relates to a kind of medicine for the treatment of asthma and preparation method thereof, be specifically related to a kind of Chinese medicine composition for the treatment of infantile asthma and preparation method thereof, belong to medical art.
Background technology
Bronchial asthma is one of modal chronic respiratory tract disease of child, and the prevalence of different regions and race has very large difference, and developed country is usually above developing country, and city is higher than rural area.China's asthma level is in ascendant trend, especially childhood asthma year by year.Chinese children asthma cooperative groups is in nineteen ninety and 2000 twice tissue whole nation childhood asthma prevalence Epidemiological study, and the average prevalence of result display childhood asthma rises to 1.54% by 0.9l%.On average 64.84% is risen between 10 years.Along with the develop rapidly of China's economic, the raising of China's industrialization and urbanization level, the living environment of people and life style there occurs huge change, and asthma prevalence has the trend risen further.
Children's is different from adult because of physiological and pathological, has the particularity of himself in Pathogenesy of Asthma.Due to the heresy that diseases caused by exogenous pathogenic factor are damp and hot, or eating and drinking without temperance, surfeit greasy and surfeit flavour, dysfunction of the spleen in transportation, damp and hot interior life, therefore part infant protracted inflammation, except performance cough with asthma, expectorant are stopped up, often with abdominal distention, stomachache, fatigue and weakness, loss of appetite, or thirsty not polydipsia, constipation or viscid not well, red tongue, thick and greasy fur, the sliding number of pulse condition, dialectically belongs to damp and hot syndrome.Modern doctor starts understanding for damp and hot asthma and payes attention to, to its theoretical research and clinical practice in further in research.
In western medicine process, the phenomenon of Clinical practice abuse of antibiotics is quite general, drug resistance is caused to increase year by year, and the phenomenon of abuse cough medicine is also very serious, not only be unprofitable to the improvement of the state of an illness, also likely increase the weight of the state of an illness, how Control of asthma, become China and even a challenge facing of the whole world, and Chinese medicine have action temperature and, onset is lasting and from the feature of basic treatment asthma.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind of Traditional Chinese medicine composition for infantile asthma, this medicine has rapid-action, that therapeutic effect is good advantage.
Present invention also offers the preparation method of this Chinese medicine composition, its preparation is simple, evident in efficacy, is convenient to suitability for industrialized production and clinical practice.
The present invention is achieved by the following technical solutions:
A kind of Traditional Chinese medicine composition for infantile asthma, is characterized in that the crude drug comprising following weight portion: Herba Artemisiae Scopariae 6 ~ 15 parts, Fructus Gardeniae 4 ~ 10 parts, Radix Sophorae Flavescentis 4 ~ 10 parts, Bulbus Fritillariae Thunbergii 4 ~ 10 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 1 ~ 5 part, Flos Matricariae chamomillae 1-5 part, Folium Eriobotryae 2 ~ 10 parts, Folium Pyrrosiae 2 ~ 8 parts, 1 ~ 5 part, Poria.Preferred crude drug consumption is: Herba Artemisiae Scopariae 12 parts, Fructus Gardeniae 6 parts, Radix Sophorae Flavescentis 6 parts, Bulbus Fritillariae Thunbergii 6 parts, 6 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 3 parts, Flos Matricariae chamomillae 3 parts, Folium Eriobotryae 6 parts, Folium Pyrrosiae 4 parts, 3 parts, Poria.
Main formula crude drug of the present invention is Herba Artemisiae Scopariae, Fructus Gardeniae, Radix Et Rhizoma Rhei, Radix Sophorae Flavescentis, Bulbus Fritillariae Thunbergii, Radix Glycyrrhizae, Flos Matricariae chamomillae, Folium Eriobotryae, Folium Pyrrosiae, Poria, by the coordinated of each crude drug, play effect of clearing away heat-damp and promoting diuresis, lung heat clearing, preventing phlegm from forming and stopping coughing, fundamentally solve asthma reason, reach the object of radical cure.Each crude drug effect is as follows:
Herba Artemisiae Scopariae, function eliminating damp-heat, sharp jaundice eliminating subcutaneous ulcer, for jaundice oliguria, hygropyrexia heat-damp in summer, eczema pruritus.
Fructus Gardeniae, function pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, vexed for calentura, jaundice due to damp-heat, the puckery pain of stranguria, heat in blood tells nosebleed, conjunctival congestion and swelling pain, pathogenic fire,toxin and furuncles.
Radix Sophorae Flavescentis, function heat clearing and damp drying, parasite killing, diuresis, for hematodiarrhoea, has blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy. external treatment trichomonal vaginitis.
Bulbus Fritillariae Thunbergii, function clearing heat, eliminating phlegm, relieving cough, detoxicating and resolving stagnation of pathogens eliminating carbuncle, for cough due to pathogenic wind-heat, phlegm-fire cough, lung abscess, acute mastitis, scrofula, sore.
Radix Glycyrrhizae, function invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, the anxious pain of gastral cavity abdomen, extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Radix Et Rhizoma Rhei, function purge heat attack long-pending, clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation, dampness removing jaundice eliminating, to stagnate constipation for excess-heat, heat in blood tells nosebleed, conjunctival congestion pharyngeal swelling, carbuncle furuncle, abdominalgia with intestinal abscess, blood stasis amenorrhea, postpartum stagnation, traumatic injury, hygropyretic dysentery, jaundice dark coloured urine, stranguria, edema.Radix et Rhizoma Rhei (stir-fried with wine) is apt to clear part of the body cavity above the diaphragm housing the heart and lungs noxious heat in the blood system, for conjunctival congestion pharyngeal swelling, and gingivitis.
Flos Matricariae chamomillae, mildly bitter flavor, Gan Xiang, there is improving eyesight, move back liver-fire, effect of expelling phlegm for arresting cough, can Cure for insomnia, reduce blood pressure, can invigorate, refresh oneself, can effectively alleviate bronchitis and asthma, the myalgia that headache, migraine or the flu of can releiving causes, centering and gastric acid, calm nerves are helpful.
Folium Eriobotryae, bitter, be slightly cold, have clearing away lung-heat to relieve cough, effect of stopping nausea and vomiting by lowering the adverse flow of QI, for cough due to lung-heat, QI rising in reverse order is panted, and gastric heat vomiting, dysphoria with smothery sensation is thirsty.
Folium Pyrrosiae, sweet, bitter, be slightly cold, have inducing diuresis for treating stranguria syndrome, effect of clearing away heat to stop bleeding, for pyretic stranguria, stranguria with blood, stone forest, urinary obstruction, drenches the puckery pain of drop, spits blood, epistaxis, hematuria, metrorrhagia, and lung-heat danger is coughed.
Poria, sweet, light, flat, have promoting diuresis to eliminate damp pathogen, effect of spleen invigorating mind calming, for edema oliguria, phlegm retention vertigo and palpitation, insufficiency of the spleen lack of appetite, have loose bowels in loose stool, irritability, palpitation with fear insomnia.
Simple for each crude drug pulverizing can directly use by medicine of the present invention, preferably prepares in the following manner:
(1) each crude drug is mixed, with the ethanol extraction 3 times of 6 ~ 10 quality, 60 ~ 85wt% doubly, each 1-2 hour, merge extractive liquid;
(2) extracting solution being condensed into relative density at 60 DEG C ~ 85 DEG C is clear paste or the thick paste of 1.20 ~ 1.40, dry, gets dry extract;
(3) dried cream powder is broken into fine powder, adds the adjuvant of survival dose, make the Chinese medicine composition of required dosage form.
Medicine of the present invention can make tablet, capsule, granule or pill.The moulding process preparing different dosage form only used is different with adjuvant, effective ingredient or the same, and therapeutic effect is also identical or approximate.The adjuvant of tablet can from starch, microcrystalline Cellulose, pregelatinized Starch, lactose, Icing Sugar, carboxymethylstach sodium, carmethose, hypromellose, polyvinylpolypyrrolidone, PVP K30, Pulvis Talci, magnesium stearate; The adjuvant of granule is select in multitudinous Icing Sugar, dextrin and correctives etc., and the adjuvant of capsule can be selected from starch, microcrystalline Cellulose, pregelatinized Starch, lactose, Icing Sugar, carboxymethylstach sodium, carmethose, hypromellose, polyvinylpolypyrrolidone, PVP K30, Pulvis Talci, magnesium stearate etc.; The adjuvant of pill can be selected from starch, microcrystalline Cellulose, pregelatinized Starch, dextrin, carboxymethylstach sodium, PVP K30, hypromellose etc.
The present invention with Herba Artemisiae Scopariae, Fructus Gardeniae, Radix Et Rhizoma Rhei, Radix Sophorae Flavescentis, Bulbus Fritillariae Thunbergii, Radix Glycyrrhizae, Flos Matricariae chamomillae, Folium Eriobotryae, Folium Pyrrosiae, Poria for major pharmaceutical component, effect of clearing away heat-damp and promoting diuresis, lung heat clearing, preventing phlegm from forming and stopping coughing is played by their synergism, can fundamentally solve asthma reason, have excellent therapeutic effect to infantile asthma.In addition, medicine preparation process of the present invention is simple, easy, has no side effect, and is convenient to promote, and is applicable to children's and uses.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, it is to be understood that following explanation is only to explain the present invention, do not limit its content.If following composition, without specified otherwise, is weight portion.
embodiment 1
Pharmaceutical formulation is as follows: Herba Artemisiae Scopariae 12 parts, Fructus Gardeniae 6 parts, Radix Sophorae Flavescentis 6 parts, Bulbus Fritillariae Thunbergii 6 parts, 6 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 3 parts, Flos Matricariae chamomillae 3 parts, Folium Eriobotryae 6 parts, Folium Pyrrosiae 4 parts, 3 parts, Poria.
Prepare according to following method:
(1) by each crude drug mixing in formula, with 8 quality doubly 80% ethanol extraction 3 times, each 2 hours, merge extractive liquid, filtration, filtrate is concentrated into the thick paste that relative density is 1.30 ~ 1.40 (80 DEG C);
(2) thick paste is mixed, dry;
(3) dried cream powder is broken into fine powder, obtains effective ingredient, then according to different needs, appropriate pharmaceutic adjuvant can be added, conventionally make the dosage form that tablet, capsule, granule, pill etc. are different.
embodiment 2
Pharmaceutical formulation is as follows: Herba Artemisiae Scopariae 6 parts, Fructus Gardeniae 10 parts, Radix Sophorae Flavescentis 4 parts, Bulbus Fritillariae Thunbergii 10 parts, 4 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 5 parts, Flos Matricariae chamomillae 1 part, Folium Eriobotryae 10 parts, Folium Pyrrosiae 2 parts, 5 parts, Poria.Preparation method is with embodiment 1.
embodiment 3
Pharmaceutical formulation is as follows: Herba Artemisiae Scopariae 15 parts, Fructus Gardeniae 4 parts, Radix Sophorae Flavescentis 10 parts, Bulbus Fritillariae Thunbergii 4 parts, 10 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 1 part, Flos Matricariae chamomillae 5 parts, Folium Eriobotryae 2 parts, Folium Pyrrosiae 8 parts, 1 part, Poria.
Preparation method is as follows:
(1) each crude drug is mixed, with the ethanol extraction 3 times of 6 quality 85wt% doubly, each 1 hour, merge extractive liquid;
(2) extracting solution being condensed into relative density at 80 DEG C is the thick paste of 1.30 ~ 1.40, dry, gets dry extract;
(3) dried cream powder is broken into fine powder, obtains effective ingredient, then according to different needs, appropriate pharmaceutic adjuvant can be added, conventionally make the dosage form that tablet, capsule, granule, pill etc. are different.
embodiment 4
Pharmaceutical formulation is as follows: Herba Artemisiae Scopariae 15 parts, Fructus Gardeniae 10 parts, Radix Sophorae Flavescentis 10 parts, Bulbus Fritillariae Thunbergii 10 parts, 10 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 5 parts, Flos Matricariae chamomillae 5 parts, Folium Eriobotryae 10 parts, Folium Pyrrosiae 8 parts, 5 parts, Poria.
Preparation method is as follows:
(1) each crude drug is mixed, with 9 quality doubly 75% ethanol extraction 3 times, each 2 hours, merge extractive liquid, filter, filtrate is concentrated into the thick paste that relative density is 1.35 ~ 1.40 (70 DEG C);
(2) thick paste is mixed, dry;
(3) dried cream powder is broken into fine powder, obtains effective ingredient, then according to different needs, appropriate pharmaceutic adjuvant can be added, conventionally make the dosage form that tablet, capsule, granule, pill etc. are different.
embodiment 5
Pharmaceutical formulation is as follows: Herba Artemisiae Scopariae 6 parts, Fructus Gardeniae 4 parts, Radix Sophorae Flavescentis 4 parts, Bulbus Fritillariae Thunbergii 4 parts, 4 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 1 part, Flos Matricariae chamomillae 1 part, Folium Eriobotryae 2 parts, Folium Pyrrosiae 2 parts, 1 part, Poria.
Preparation method is as follows:
(1) by each crude drug mixing in formula, add 60% ethanol extraction 3 times of crude drug gross mass 10 times, each 2 hours, merge extractive liquid, filter, filtrate is concentrated into the thick paste that relative density is 1.25 ~ 1.35 (85 DEG C);
(2) thick paste is mixed, dry;
(3) dried cream powder is broken into fine powder, obtains effective ingredient, then according to different needs, appropriate pharmaceutic adjuvant can be added, conventionally make the dosage form that tablet, capsule, granule, pill etc. are different.
Compositions of the present invention has no side effect, and can effect a radical cure asthma, and treatment cycle is short, rapid-action, carries out clinical experiment below to medicine of the present invention, proves its effect.
clinical trial
1, physical data
174 routine symptoms of asthma infants are screened, wherein man 90 example, female 84 example from Shandong Traditional Chinese Medicine University's attached hospital of traditional Chinese hospital outpatient service, 3 ~ 14 years old age, 7.16 ± 1.58 years old mean age, average course of disease 4.47 ± 2.07 years, each infant all meets the inclusive criteria of this clinical observation.Each group of patient anticipates (P>0.05) without statistics at sex, age, course of disease comparing difference, has comparability.
2, inclusive criteria
1. Western medicine diagnose standard (with reference to the revision " children with asthma diagnosis and treatment guide " in 2008 of department of pediatrics branch of Chinese Medical Association pneumatology group) is met
2. TCM syndrome diagnostic criteria is met;
Formulate with reference to " TCM syndrome diagnostic criteria " content relevant in " Chinese medical disease Standardization of diagnosis and curative effect ", " new Chinese medicine clinical guidance principle " (2002) " bronchial wheezing " and " the senior book series Pediatrics of Chinese Medicine of Chinese medicine " (second edition) " asthma " that State Administration of Traditional Chinese Medicine issues for 1994.
Primary symptom: cough with asthma is out of breath, wheezing in larynx, expectoration thickness.
Secondary disease: heating, nausea and vomiting, poor appetite, abdominal distention, constipation or sticky, yellowish or reddish urine.
Tongue fur pulse condition: red tongue, thick and greasy fur, slippery and rapid pulse, or fingerprint is purple.
In above-mentioned standard, need possess main symptom 2, secondary card more than 2, tongue fur is indispensable, and diagnosable is damp and hot asthma.
3. severity Scaling belong to gently, moderate person; 4. Informed Consent Form person is signed.
3, exclusion standard
1. diagnostic criteria and inclusive criteria person is not met; 2. the serious heart, liver, kidney, lung disease or congenital diseases are had; 3. severity is the children with bronchial asthma disease of severe and the person that occurs severe attack after including in; 4. to institute medicine allergy sufferers.
4, Therapeutic Method
Infant is equally divided into 3 groups, often organize the medicine that infant uses the embodiment of the present invention 1,2 and 4 respectively, application method is a 6g, three times on the one, treats 14 days, observe the curative effect.
5, criterion of therapeutical effect
Criterion of therapeutical effect is drafted with reference to " new Chinese medicine guideline of clinical investigations ".
Clinic control: symptoms of asthma complete incidence graph, even if there is mild episode not need medication to alleviate once in a while, FEV l(or PEF) recruitment >35%, or FEV after treatment l(PEF)>=8O% predicted value.PEF day and night fluctuation rate <20%.
Effective: obviously to alleviate before asthma attack comparatively, FEV 1(or PEF) recruitment scope 25% ~ 35%, or FEV after treatment 1(PEF) reach predicted value 60% ~ 79%, PEF day and night fluctuation rate >20%, still need with glucocorticoid or bronchodilator.
Take a turn for the better: symptoms of asthma alleviates to some extent, FEV 1(or PEF) recruitment 15% ~ 24%, still need with glucocorticoid or (with) bronchodilator.
Invalid: clinical symptoms and FEV 1(or PEF) measured value is without improvement or increase the weight of on the contrary.
6, clinical efficacy result
Above-mentioned patient overwhelming majority when treating shows good effect, and rapid-action.Above-mentioned treatment basis continues to take this medicine 6 months, and except refractory patient, other are all fully recovered, and follow up a case by regular visits to 1 year without recidivist.And during drug administration, have no adverse reaction generation, illustrates that medicine of the present invention has no side effect substantially to human body.

Claims (4)

1. a Traditional Chinese medicine composition for infantile asthma, it is characterized in that with parts by weight, its crude drug consists of: Herba Artemisiae Scopariae 6 ~ 15 parts, Fructus Gardeniae 4 ~ 10 parts, Radix Sophorae Flavescentis 4 ~ 10 parts, Bulbus Fritillariae Thunbergii 4 ~ 10 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 1 ~ 5 part, Flos Matricariae chamomillae 1-5 part, Folium Eriobotryae 2 ~ 10 parts, Folium Pyrrosiae 2 ~ 8 parts, 1 ~ 5 part, Poria.
2. Traditional Chinese medicine composition for infantile asthma according to claim 1, it is characterized in that with parts by weight, its crude drug consists of: Herba Artemisiae Scopariae 12 parts, Fructus Gardeniae 6 parts, Radix Sophorae Flavescentis 6 parts, Bulbus Fritillariae Thunbergii 6 parts, 6 parts, Radix Glycyrrhizae, Radix Et Rhizoma Rhei 3 parts, Flos Matricariae chamomillae 3 parts, Folium Eriobotryae 6 parts, Folium Pyrrosiae 4 parts, 3 parts, Poria.
3. Traditional Chinese medicine composition for infantile asthma according to claim 1 and 2, is characterized in that: dosage form is tablet, capsule, granule or pill.
4. a preparation method for Traditional Chinese medicine composition for infantile asthma according to claim 3, is characterized in that comprising the following steps:
(1) each crude drug is mixed, with the ethanol extraction 3 times of 6 ~ 10 quality, 60 ~ 85wt% doubly, each 1-2 hour, merge extractive liquid;
(2) extracting solution being condensed into relative density at 60 DEG C ~ 85 DEG C is clear paste or the thick paste of 1.20 ~ 1.40, dry, gets dry extract;
(3) dried cream powder is broken into fine powder, adds the adjuvant of survival dose, make the Chinese medicine composition of required dosage form.
CN201310440763.3A 2013-09-25 2013-09-25 Traditional Chinese medicine composition for infantile asthma and preparation method thereof Active CN103463402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310440763.3A CN103463402B (en) 2013-09-25 2013-09-25 Traditional Chinese medicine composition for infantile asthma and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310440763.3A CN103463402B (en) 2013-09-25 2013-09-25 Traditional Chinese medicine composition for infantile asthma and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103463402A CN103463402A (en) 2013-12-25
CN103463402B true CN103463402B (en) 2015-01-14

Family

ID=49788594

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310440763.3A Active CN103463402B (en) 2013-09-25 2013-09-25 Traditional Chinese medicine composition for infantile asthma and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103463402B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989831A (en) * 2014-06-13 2014-08-20 强红枫 Traditional Chinese medicine composition for treating infantile asthma and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083525A (en) * 2013-01-10 2013-05-08 中国医学科学院药用植物研究所 Traditional Chinese medicine composition for treating asthma, as well as preparation method and use of composition

Also Published As

Publication number Publication date
CN103463402A (en) 2013-12-25

Similar Documents

Publication Publication Date Title
CN1325083C (en) Medicinal composition for removing dampness to relieve itching and its preparation method and uses
CN102698137B (en) Composition with blood pressure reducing function and preparation method of same
CN102309687B (en) Medicament for treating faucitis
CN103463399B (en) Medicament for treating infantile asthma and preparation method thereof
CN103394002B (en) Medicinal composition for treating cutaneous pruritus as well as preparation method and application thereof
CN103463400B (en) Chinese medicine composition for treating infantile asthma
CN103055218B (en) Traditional Chinese medicine composition for treating neonatal jaundice and preparation method thereof
CN103463402B (en) Traditional Chinese medicine composition for infantile asthma and preparation method thereof
CN102210773B (en) Chinese medicinal cataplasm for treating infantile pneumonia, preparation method thereof and application thereof
CN103463401B (en) Asthma medicine for infants
CN103463537B (en) Medicament for treating infantile asthma
CN105126008A (en) Traditional Chinese medicine combination for treating infantile diarrhea and preparation method thereof
CN105327182A (en) Medicine for treating child pertussis and preparation method thereof
CN103007145B (en) Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition
CN104800675A (en) Medicament for treating active ulcerative colitis
CN103463403B (en) Pharmaceutical composition for infantile asthma
CN101708286A (en) Chinese patent medicament for treating sjogren&#39;s syndrome and intractable oral ulcer, and preparation method thereof
CN103961562A (en) Concentrated oral solution for treating recurrent oral ulcer by type of fire excess from yin deficiency
CN103877484A (en) Traditional Chinese medicine oral liquid for treating oral liquid
CN103495120B (en) A kind of Chinese medicine composition for the treatment of pelvic inflammatory disease and preparation method thereof
CN103520514A (en) Traditional Chinese medicinal decoction for treating cough-type asthma of children
CN103520638B (en) A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof
CN103585580B (en) A kind of Chinese medicine preparation for recurrent oral ulceration
CN106074824A (en) Enhancing immunity and the compositions of prophylactic treatment influenza, preparation technology and purposes
CN105168397A (en) Medicine composition for preventing and treating nephrosis

Legal Events

Date Code Title Description
PB01 Publication
C06 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
GR01 Patent grant
C14 Grant of patent or utility model
TR01 Transfer of patent right

Effective date of registration: 20200701

Address after: 250014, No. ten, No. 16369, Ji'nan, Shandong

Patentee after: SHANDONG University OF TRADITIONAL CHINESE MEDICINE

Address before: 250014 1206, building 1, building 89, No. 9, No. ten, Lixia Road, Lixia District, Shandong, Ji'nan

Patentee before: Li Yanning

TR01 Transfer of patent right